COVID-19 Outbreak-Global Quetiapine (Cas 111974-69-7) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 120
Quetiapine is an atypical antipsychotic approved for the treatment of schizophrenia, bipolar disorder, and antidepressants for major depression. It is also sometimes used as a sleep aid. The Quetiapine (Cas 111974-69-7)....
COVID-19 Outbreak-Global Dental CAD&CAM Systems Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 122
The Dental CAD&CAM Systems market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally,....
COVID-19 Outbreak-Global Hydroponic Nutrients Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 104
Hydroponics is a new type of hydroponic flower cultivated using soilless cultivation techniques and cultivated with nutrient solution. The core is that the nutrient solution replaces the soil to provide....
COVID-19 Outbreak-Global Peptide Therapeutics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 104
The Peptide Therapeutics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak globally, this....
COVID-19 Outbreak-Global Aesthetic Medicine and Cosmetics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020
By Maia Research | Pharmaceuticals and Healthcare | Aug 2020 | Page 125
The Aesthetic Medicine and Cosmetics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Under COVID-19 outbreak....